Annual ROE
-127.71%
-69.56%-119.62%
December 31, 2023
Summary
- As of February 8, 2025, INDP annual return on equity is -127.71%, with the most recent change of -69.56% (-119.62%) on December 31, 2023.
- During the last 3 years, INDP annual ROE has fallen by -1635.58% (-108.47%).
- INDP annual ROE is now -108.47% below its all-time high of 1507.87%, reached on December 31, 2020.
Performance
INDP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-177.27%
-30.57%-20.84%
September 1, 2024
Summary
- As of February 8, 2025, INDP quarterly return on equity is -177.27%, with the most recent change of -30.57% (-20.84%) on September 1, 2024.
- Over the past year, INDP quarterly ROE has dropped by -30.57% (-20.84%).
- INDP quarterly ROE is now -107.18% below its all-time high of 2470.47%, reached on March 31, 2021.
Performance
INDP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
INDP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -119.6% | -20.8% |
| 3 y3 years | -108.5% | -178.9% |
| 5 y5 years | -108.5% | -178.9% |
INDP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -494.6% | at low | -573.8% | at low |
| 5 y | 5-year | -108.5% | at low | -107.2% | at low |
| alltime | all time | -108.5% | at low | -107.2% | at low |
Indaptus Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -177.27%(+20.8%) |
| Jun 2024 | - | -146.70%(+35.7%) |
| Mar 2024 | - | -108.14%(+17.8%) |
| Dec 2023 | -127.71%(+119.6%) | -91.78%(+21.4%) |
| Sep 2023 | - | -75.59%(+18.9%) |
| Jun 2023 | - | -63.56%(+8.4%) |
| Mar 2023 | - | -58.62%(+18.6%) |
| Dec 2022 | -58.15% | -49.41%(+13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -43.65%(+9.0%) |
| Jun 2022 | - | -40.03%(+16.0%) |
| Mar 2022 | - | -34.52%(+31.2%) |
| Dec 2021 | -21.48%(-101.4%) | -26.31%(-13.8%) |
| Sep 2021 | - | -30.51%(-39.3%) |
| Jun 2021 | - | -50.24%(-102.0%) |
| Mar 2021 | - | 2470.47%(+11.6%) |
| Dec 2020 | 1507.87% | - |
| Dec 2020 | - | 2212.83% |
FAQ
- What is Indaptus Therapeutics annual return on equity?
- What is the all time high annual ROE for Indaptus Therapeutics?
- What is Indaptus Therapeutics annual ROE year-on-year change?
- What is Indaptus Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Indaptus Therapeutics?
- What is Indaptus Therapeutics quarterly ROE year-on-year change?
What is Indaptus Therapeutics annual return on equity?
The current annual ROE of INDP is -127.71%
What is the all time high annual ROE for Indaptus Therapeutics?
Indaptus Therapeutics all-time high annual return on equity is 1507.87%
What is Indaptus Therapeutics annual ROE year-on-year change?
Over the past year, INDP annual return on equity has changed by -69.56% (-119.62%)
What is Indaptus Therapeutics quarterly return on equity?
The current quarterly ROE of INDP is -177.27%
What is the all time high quarterly ROE for Indaptus Therapeutics?
Indaptus Therapeutics all-time high quarterly return on equity is 2470.47%
What is Indaptus Therapeutics quarterly ROE year-on-year change?
Over the past year, INDP quarterly return on equity has changed by -30.57% (-20.84%)